Director/PDMR Shareholding
Dr. Martens plc has announced that on October 15, 2026, restricted stock units granted to CEO Ije Nwokorie vested, and on October 16, 2026, 209,160 ordinary shares were sold at £0.692483 each on his behalf to cover tax and national insurance liabilities, following the acquisition of 443,457 shares. This transaction relates to a buyout award made to Mr. Nwokorie in June 2024.
Select text to share a quote on X · sign in to keep highlights & notes in your DOCS notes
- Martens plc (the 'Company') announces that it has been notified of the following transaction(s) in the Company's Ordinary 1p shares undertaken on behalf of a director and person discharging managerial responsibility ('PDMR').
On 15 October 2026, a tranche of restricted stock units ('RSUs') granted to Ije Nwokorie under the Company's Long Term Incentive Plan ('LTIP') prior to his appointment as Chief Executive Officer vested and, on 16 October 2026, sufficient shares were sold on his behalf to cover his consequent tax and national insurance liabilities.
This tranche constitutes a portion of the RSU award which was granted to Ije on 14 June 2024 in lieu of outstanding incentive awards he forfeited on leaving his previous employer (the Award). The Award was made pursuant to the buyout arrangements agreed to secure Ije's recruitment to his previous role as Chief Brand Officer, which he held from February 2024 until he became Chief Executive Officer in January 2025, and in line with the stipulations of the Company's Remuneration Policy that 'buyout awards' be granted on a like-for-like basis to the extent possible. Full details of awards made to Ije under the LTIP will be disclosed in the Directors' Remuneration Report within the FY27 Annual Report, scheduled to be published in June 2027.
| 1 | Details of the person discharging managerial responsibilities/person closely associated | |||||
| a) | Name | Ije Nwokorie | ||||
| 2 | Reason for the notification | |||||
| a) | Position/status | PDMR (Chief Executive Officer) | ||||
| b) | Initial notification/Amendment | Initial notification | ||||
| a) | Name | Dr. Martens plc | ||||
| b) | LEI | 213800QPT8YM6NQZPH28 | ||||
| a) | Description of the financial instrument, type of instrument Identification code | Ordinary shares of GBP 0.01 ISIN: GB00BL6NGV24 | ||||
| b) | Nature of the transaction | Acquisition of shares following vesting of restricted stock units | ||||
| c) | Price(s) and volume(s) | Price(s) Volume(s) Nil 443,457 | ||||
| d) | Aggregated information - Aggregated volume - Price | N/A - single transaction | ||||
| e) | Date of the transaction | 16 October 2026 | ||||
| f) | Place of the transaction | Outside a trading venue | ||||
| 1 | Details of the person discharging managerial responsibilities/person closely associated | |||||
| a) | Name | Ije Nwokorie | ||||
| 2 | Reason for the notification | |||||
| a) | Position/status | PDMR (Chief Executive Officer) | ||||
| b) | Initial notification/Amendment | Initial notification | ||||
| a) | Name | Dr. Martens plc | ||||
| b) | LEI | 213800QPT8YM6NQZPH28 | ||||
| a) | Description of the financial instrument, type of instrument Identification code | Ordinary shares of GBP 0.01 ISIN: GB00BL6NGV24 | ||||
| c) | Price(s) and volume(s) |
| ||||
| d) | Aggregated information - Aggregated volume - Price | N/A - single transaction | ||||
| e) | Date of the transaction | 16 October 2026 | ||||
| f) | Place of the transaction | XLON |
Cleaned text: letterheads, contacts and legal notices removed. View the original announcement ↗ · Company filings. Not investment advice.